Cytokinetics Inc/ US23282W6057 /
2024-03-28 9:00:00 PM | Chg. -1.3000 | Volume | Bid12:57:45 AM | Ask12:57:45 AM | High | Low |
---|---|---|---|---|---|---|
70.1100USD | -1.82% | 1.61 mill. Turnover: 84.76 mill. |
70.2000Bid Size: 100 | 71.7500Ask Size: 800 | 71.8550 | 69.9600 |
GlobeNewswire
03-25
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual...
GlobeNewswire
02-29
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
GlobeNewswire
02-28
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase E...
GlobeNewswire
02-06
Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire
01-29
Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program
GlobeNewswire
01-25
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial...
GlobeNewswire
2023-12-27
Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Afi...
GlobeNewswire
2023-12-26
Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, t...
GlobeNewswire
2023-12-12
Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support F...
GlobeNewswire
2023-12-07
Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND
GlobeNewswire
2023-12-01
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2023-11-29
Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND
GlobeNewswire
2023-11-03
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)